Trailing-twelve-month (TTM) revenue is $44.52 Billion with a year-over-year growth of +2.55%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $11,477,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-23 |
| Q4 FY2025Period ended 2025-12-31 | $11,375,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-10 |
| Q1 FY2026Period ended 2026-03-31 | $10,796,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-23 |
| Q2 FY2026Period ended 2026-06-30 | $10,874,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-23 |
| TTM revenue | $44,522,000,000 |
Current P/S: $10,090,782,000 market capitalization ÷ $44,522,000,000 TTM revenue = 0.23x.
Market capitalization source: FMP quote. Quote observed 2026-09-24T20:00:02.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $10.87B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-25T00:15:51.724Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Marketplace | N/A | N/A | $3.1B | $2.3B | $2.5B | $4.5B |
| Medicaid Solutions Segment | N/A | N/A |
$44.52B
$44.52 Billion
+2.55%
vs. $43.41B a year ago (TTM)
+13.56%
5 Year compound annual growth rate
1 Year
+2.55%
3 Year
+10.92%
5 Year
+13.56%
10 Year
+10.72%
15 Year
+16.67%
20 Year
+17.43%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $45.43B | +$4.78B | +11.75% |
| 2024 | $40.65B | +$6.58B | +19.31% |
| 2023 | $34.07B | +$2.10B | +6.56% |
| 2022 | $31.97B | +$4.20B | +15.13% |
| 2021 | $27.77B | +$8.35B | +42.98% |
| 2020 |
TTM Growth
+2.55%
3-Year CAGR
+10.92%
5-Year CAGR
+13.56%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-25T00:15:51.724Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
| $25.8B |
| $30.6B |
| $32.2B |
| Medicare | N/A | N/A | $3.4B | $3.8B | $5.5B | $6.2B |
|---|
| Other Segments | $14M | $8M | $70M | $71M | $81M | $177M |
|---|
| $19.42B |
| +$2.59B |
| +15.41% |
| 2019 | $16.83B | ($2.06B) | (10.91%) |
| 2018 | $18.89B | ($993.00M) | (4.99%) |
| 2017 | $19.88B | +$2.17B | +12.26% |
| 2016 | $17.71B | +$3.64B | +25.86% |
